[Treatment of maxillary cancer].
The experience of the Moscow Research Institute of Oncology named after P. A. Herzen with the treatment of 368 primary patients with malignant tumors of the upper jaw, and the analysis of the literature data allowed a formulation of basic tendencies in therapy of this affection. These include a wide use of the combination therapy with preoperative radiation treatment; an elaboration of some extended variants of surgical interventions; an improvement of radiation technics, use of drug therapy, mainly as regional chemotherapy associated with radiotherapy. Further elaboration of the early diagnostics is also of importance. Patients in whom malignant tumors of the upper jaw were detected should be treated in specialized oncological departments, specially equipped and having well-trained medical staff.
D002360:Carubicin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008441:Maxillary Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008727:Methotrexate / Q000008:administration & dosage; D011447:Prospidium / Q000008:administration & dosage; D011867:Radioisotope Teletherapy; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D011447:Prospidium; D003520:Cyclophosphamide; D002360:Carubicin; D005472:Fluorouracil; D008727:Methotrexate
O lechenii raka verkhneĭ cheliusti.